{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:35Z","timestamp":1790998235284,"version":"4.1.0"},"reference-count":40,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2022]]},"DOI":"10.1620\/tjem.2022.j036","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T22:10:01Z","timestamp":1651097401000},"page":"211-224","source":"Crossref","is-referenced-by-count":7,"title":["TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid Leukemia"],"prefix":"10.1620","volume":"257","author":[{"given":"Katsuyuki","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"},{"name":"Laboratory Diagnostics, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"},{"name":"Laboratory Diagnostics, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koya","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Graduate School of Medicine"},{"name":"Laboratory Diagnostics, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Amarante-Mendes, G.P., Rana, A., Datoguia, T.S., Hamerschlak, N. &amp; Brumatti, G.(2022)  BCR-ABL1 tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid leukemia.  <i>Pharmaceutics<\/i>, 14, 215.","DOI":"10.3390\/pharmaceutics14010215"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Beauchemin, H. &amp; M\u00f6r\u00f6y, T.(2020)  Multifaceted actions of GFI1 and GFI1B in hematopoietic stem cell self-renewal and lineage commitment.  <i>Front. Genet.<\/i>, 11, 591099.","DOI":"10.3389\/fgene.2020.591099"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bernot, D., Stalin, J., Stocker, P., Bonardo, B., Scroyen, I., Alessi, M.C. &amp; Peiretti, F.(2011)  Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase.  <i>J. Cell Sci<\/i>., 124, 1224-1230.","DOI":"10.1242\/jcs.079889"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D.S., Sawyers, C.L., Arber, D.A., Slovak, M.L. &amp; Forman, S.J.(2003)  Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.  <i>Blood<\/i>, 101, 4701-4707.","DOI":"10.1182\/blood-2002-09-2780"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Carr\u00e0, G., Torti, D., Crivellaro, S., Panuzzo, C., Taulli, R., Cilloni, D., Guerrasio, A., Saglio, G. &amp; Morotti, A.(2016)  The BCR-ABL\/NF-kappaB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.  <i>Oncotarget<\/i>, 7, 66287-66298.","DOI":"10.18632\/oncotarget.11507"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Collins, S.J., Gallo, R.C. &amp; Gallagher, R.E.(1977)  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.  <i>Nature<\/i>, 270, 347-349.","DOI":"10.1038\/270347a0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Corbin, A.S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M.W. &amp; Druker, B.J.(2011)  Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.  <i>J. Clin. Invest<\/i>., 121, 396-409.","DOI":"10.1172\/JCI35721"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Delgado, M.D., Gutierrez, P., Richard, C., Cuadrado, M.A., Moreau-Gachelin, F. &amp; Leon, J.(1998)  Spi-1\/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.  <i>Biochem. Biophys. Res. Commun<\/i>., 252, 383-391.","DOI":"10.1006\/bbrc.1998.9587"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Druker, B.J., Guilhot, F., O\u2019Brien, S.G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M.W., Silver, R.T., Goldman, J.M., Stone, R.M., Cervantes, F., Hochhaus, A., Powell, B.L., Gabrilove, J.L., Rousselot, P.,  et al.(2006)  Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.  <i>N. Engl. J. Med<\/i>., 355, 2408-2417.","DOI":"10.1056\/NEJMoa062867"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Etienne, G., Guilhot, J., Rea, D., Rigal-Huguet, F., Nicolini, F., Charbonnier, A., Guerci-Bresler, A., Legros, L., Varet, B., Gardembas, M., Dubruille, V., Tulliez, M., Noel, M.P., Ianotto, J.C., Villemagne, B.,  et al.(2017)  Long-term follow-up of the French stop imatinib (STIM1)  study in patients with chronic myeloid leukemia.  <i>J. Clin. Oncol<\/i>., 35, 298-305.","DOI":"10.1200\/JCO.2016.68.2914"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fujiwara, T., Okamoto, K., Niikuni, R., Takahashi, K., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., Ichinohasama, R., Nakamura, Y., Nakajima, M., Tanaka, T. &amp; Harigae, H.(2014)  Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.  <i>Biochem. Biophys. Res. Commun<\/i>., 454, 102-108.","DOI":"10.1016\/j.bbrc.2014.10.050"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fujiwara, T., Sasaki, K., Saito, K., Hatta, S., Ichikawa, S., Kobayashi, M., Okitsu, Y., Fukuhara, N., Onishi, Y. &amp; Harigae, H.(2017)  Forced FOG1 expression in erythroleukemia cells: induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1. <i>Biochem. Biophys. Res. Commun.<\/i>, 485, 380-387.","DOI":"10.1016\/j.bbrc.2017.02.068"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ghosh, A.K. &amp; Vaughan, D.E.(2012)  PAI-1 in tissue fibrosis.  <i>J. Cell. Physiol<\/i>., 227, 493-507.","DOI":"10.1002\/jcp.22783"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Grabher, C., von Boehmer, H. &amp; Look, A.T.(2006)  Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.  <i>Nat. Rev. Cancer<\/i>, 6, 347-359.","DOI":"10.1038\/nrc1880"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hochhaus, A., Larson, R.A., Guilhot, F., Radich, J.P., Branford, S., Hughes, T.P., Baccarani, M., Deininger, M.W., Cervantes, F., Fujihara, S., Ortmann, C.E., Menssen, H.D., Kantarjian, H., O&apos;Brien, S.G., Druker, B.J.,  et al.(2017)  Long-term outcomes of imatinib treatment for chronic myeloid leukemia.  <i>N. Engl. J. Med<\/i>., 376, 917-927.","DOI":"10.1056\/NEJMoa1609324"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Huntly, B.J. &amp; Gilliland, D.G.(2005)  Leukaemia stem cells and the evolution of cancer-stem-cell research.  <i>Nat. Rev. Cancer<\/i>, 5, 311-321.","DOI":"10.1038\/nrc1592"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ibrahim, A.A., Yahata, T., Onizuka, M., Dan, T., Van Ypersele De Strihou, C., Miyata, T. &amp; Ando, K.(2014)  Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration.  <i>Stem Cells<\/i>, 32, 946-958.","DOI":"10.1002\/stem.1577"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ismail, A.A., Shaker, B.T. &amp; Bajou, K.(2021)  The plasminogen-activator plasmin system in physiological and pathophysiological angiogenesis.  <i>Int. J. Mol. Sci.<\/i>, 23, 337.","DOI":"10.3390\/ijms23010337"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Klinakis, A., Lobry, C., Abdel-Wahab, O., Oh, P., Haeno, H., Buonamici, S., van De Walle, I., Cathelin, S., Trimarchi, T., Araldi, E., Liu, C., Ibrahim, S., Beran, M., Zavadil, J., Efstratiadis, A.,  et al. (2011)  A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.  <i>Nature<\/i>, 473, 230-233.","DOI":"10.1038\/nature09999"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Koldehoff, M., Zakrzewski, J.L., Beelen, D.W. &amp; Elmaagacli, A.H.(2013)  Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.  <i>Cancer Gene Ther<\/i>., 20, 421-427.","DOI":"10.1038\/cgt.2013.31"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lounnas, N., Frelin, C., Gonthier, N., Colosetti, P., Sirvent, A., Cassuto, J.P., Berthier, F., Sirvent, N., Rousselot, P., Dreano, M., Peyron, J.F. &amp; Imbert, V.(2009)  NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.  <i>Int. J. Cancer<\/i>, 125, 308-317.","DOI":"10.1002\/ijc.24294"},{"key":"22","doi-asserted-by":"crossref","unstructured":"McCarter, A.C., Wang, Q. &amp; Chiang, M.(2018)  Notch in leukemia.  <i>Adv. Exp. Med. Biol<\/i>., 1066, 355-394.","DOI":"10.1007\/978-3-319-89512-3_18"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Mosser, D.D., Caron, A.W., Bourget, L., Meriin, A.B., Sherman, M.Y., Morimoto, R.I. &amp; Massie, B.(2000)  The chaperone function of hsp70 is required for protection against stress-induced apoptosis.  <i>Mol. Cell. Biol<\/i>., 20, 7146-7159.","DOI":"10.1128\/MCB.20.19.7146-7159.2000"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Niu, M., Zhang, B., Li, L., Su, Z., Pu, W., Zhao, C., Wei, L., Lian, P., Lu, R., Wang, R., Wazir, J., Gao, Q., Song, S. &amp; Wang, H.(2021)  Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1\/ERK pathway in lung cancer.  <i>Front. Pharmacol.<\/i>, 12, 724192.","DOI":"10.3389\/fphar.2021.724192"},{"key":"25","unstructured":"Nowell, P.C. &amp; Hungerford, D.A.(1960)  Chromosome studies on normal and leukemic human leukocytes.  <i>J. Natl. Cancer Inst<\/i>., 25, 85-109."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G., Salvatore, F. &amp; Rotoli, B.(1996)  Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction).  <i>Blood<\/i>, 88, 2410-2414.","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Poon, I.K., Hulett, M.D. &amp; Parish, C.R.(2010)  Molecular mechanisms of late apoptotic\/necrotic cell clearance.  <i>Cell Death Differ<\/i>., 17, 381-397.","DOI":"10.1038\/cdd.2009.195"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Saito, K., Fujiwara, T., Hatta, S., Morita, M., Ono, K., Suzuki, C., Fukuhara, N., Onishi, Y., Nakamura, Y., Kawamata, S., Shimizu, R., Yamamoto, M. &amp; Harigae, H.(2019)  Generation and molecular characterization of human ring sideroblasts: a key role of ferrous iron in terminal erythroid differentiation and ring sideroblast formation.  <i>Mol. Cell. Biol.<\/i>, 39, e00387-18.","DOI":"10.1128\/MCB.00387-18"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Scott, E.W., Simon, M.C., Anastasi, J. &amp; Singh, H.(1994)  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.  <i>Science<\/i>, 265, 1573-1577.","DOI":"10.1126\/science.8079170"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Segawa, K. &amp; Nagata, S.(2015)  An apoptotic &apos;eat me&apos; signal: phosphatidylserine exposure.  <i>Trends Cell Biol<\/i>., 25, 639-650.","DOI":"10.1016\/j.tcb.2015.08.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Thandapani, P., Kloetgen, A., Witkowski, M.T., Glytsou, C., Lee, A.K., Wang, E., Wang, J., LeBoeuf, S.E., Avrampou, K., Papagiannakopoulos, T., Tsirigos, A. &amp; Aifantis, I.(2022)  Valine tRNA levels and availability regulate complex I assembly in leukaemia.  <i>Nature<\/i>, 601, 428-433.","DOI":"10.1038\/s41586-021-04244-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Van De Craen, B., Declerck, P.J. &amp; Gils, A.(2012)  The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.  <i>Thromb. Res<\/i>., 130, 576-585.","DOI":"10.1016\/j.thromres.2012.06.023"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Walker, L.C., Ganesan, T.S., Dhut, S., Gibbons, B., Lister, T.A., Rothbard, J. &amp; Young, B.D.(1987)  Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia.  <i>Nature<\/i>, 329, 851-853.","DOI":"10.1038\/329851a0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wu, J. &amp; Bresnick, E.H.(2007)  Bare rudiments of notch signaling: how receptor levels are regulated.  <i>Trends Biochem. Sci<\/i>., 32, 477-485.","DOI":"10.1016\/j.tibs.2007.09.002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Yahata, T., Ibrahim, A.A., Hirano, K.I., Muguruma, Y., Naka, K., Hozumi, K., Vaughan, D.E., Miyata, T. &amp; Ando, K.(2021)  Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells.  <i>Haematologica<\/i>, 106, 483-494.","DOI":"10.3324\/haematol.2019.230227"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Yahata, T., Ibrahim, A.A., Muguruma, Y., Eren, M., Shaffer, A.M., Watanabe, N., Kaneko, S., Nakabayashi, T., Dan, T., Hirayama, N., Vaughan, D.E., Miyata, T. &amp; Ando, K.(2017)  TGF-beta-induced intracellular PAI-1 is responsible for retaining hematopoietic stem cells in the niche.  <i>Blood<\/i>, 130, 2283-2294.","DOI":"10.1182\/blood-2017-02-767384"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yamaoka, N., Murano, K., Kodama, H., Maeda, A., Dan, T., Nakabayashi, T., Miyata, T. &amp; Meguro, K.(2018)  Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: structure optimization of N-acylanthranilic acid derivatives.  <i>Bioorg. Med. Chem. Lett<\/i>., 28, 809-813.","DOI":"10.1016\/j.bmcl.2017.11.016"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yin, D.D., Fan, F.Y., Hu, X.B., Hou, L.H., Zhang, X.P., Liu, L., Liang, Y.M. &amp; Han, H.(2009)  Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562.  <i>Leuk. Res<\/i>., 33, 109-114.","DOI":"10.1016\/j.leukres.2008.06.023"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Zelko, I.N., Mariani, T.J. &amp; Folz, R.J.(2002)  Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3)  gene structures, evolution, and expression.  <i>Free Radic. Biol. Med<\/i>., 33, 337-349.","DOI":"10.1016\/S0891-5849(02)00905-X"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A.H., Tanaseichuk, O., Benner, C. &amp; Chanda, S.K.(2019)  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.  <i>Nat. Commun.<\/i>, 10, 1523.","DOI":"10.1038\/s41467-019-09234-6"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/257\/3\/257_2022.J036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:20:22Z","timestamp":1715232022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/257\/3\/257_2022.J036\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2022.j036","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022.J036"}}